STAAR Surgical Revenue 2010-2025 | STAA

STAAR Surgical revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
STAAR Surgical Annual Revenue
(Millions of US $)
2024 $314
2023 $322
2022 $284
2021 $230
2020 $163
2019 $150
2018 $124
2017 $91
2016 $82
2015 $77
2014 $75
2013 $72
2012 $64
2011 $63
2010 $55
2009 $51
STAAR Surgical Quarterly Revenue
(Millions of US $)
2025-03-31 $43
2024-12-31 $49
2024-09-30 $89
2024-06-30 $99
2024-03-31 $77
2023-12-31 $76
2023-09-30 $80
2023-06-30 $92
2023-03-31 $74
2022-12-31 $64
2022-09-30 $76
2022-06-30 $81
2022-03-31 $63
2021-12-31 $59
2021-09-30 $58
2021-06-30 $62
2021-03-31 $51
2020-12-31 $46
2020-09-30 $47
2020-06-30 $35
2020-03-31 $35
2019-12-31 $39
2019-09-30 $39
2019-06-30 $40
2019-03-31 $33
2018-12-31 $31
2018-09-30 $32
2018-06-30 $34
2018-03-31 $27
2017-12-31 $25
2017-09-30 $23
2017-06-30 $22
2017-03-31 $20
2016-12-31 $22
2016-09-30 $20
2016-06-30 $21
2016-03-31 $19
2015-12-31 $21
2015-09-30 $19
2015-06-30 $19
2015-03-31 $19
2014-12-31 $17
2014-09-30 $18
2014-06-30 $20
2014-03-31 $20
2013-12-31 $19
2013-09-30 $17
2013-06-30 $18
2013-03-31 $18
2012-12-31 $16
2012-09-30 $16
2012-06-30 $16
2012-03-31 $16
2011-12-31 $16
2011-09-30 $15
2011-06-30 $16
2011-03-31 $15
2010-12-31 $14
2010-09-30 $13
2010-06-30 $14
2010-03-31 $14
2009-12-31 $13
2009-09-30 $12
2009-06-30 $13
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.827B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.300B 21.81
Becton Dickinson (BDX) United States $48.551B 12.02
Cardinal Health (CAH) United States $37.055B 19.41
Labcorp (LH) United States $20.745B 16.83
Straumann Holding AG (SAUHY) Switzerland $20.458B 0.00
West Pharmaceutical Services (WST) United States $15.044B 31.53
Cooper (COO) United States $13.399B 17.27
Align Technology (ALGN) United States $12.939B 25.68
Henry Schein (HSIC) United States $8.467B 14.52
Merit Medical Systems (MMSI) United States $5.534B 26.75
DENTSPLY SIRONA (XRAY) United States $3.113B 9.30
CONMED (CNMD) United States $1.713B 12.82
Lifevantage (LFVN) United States $0.157B 16.17
Pro-Dex (PDEX) United States $0.128B 14.01